Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.40 |
| ▸ | PPARG | P37231 | 7/20 | 0.40 |
| ▸ | PPARD | Q03181 | 7/20 | 0.40 |
| ▸ | PPARA | Q07869 | 7/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.40 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21269781 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL28315863 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL28316150 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| Lithium SCHEMBL29455930 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| Hydrochloric Acid SCHEMBL10521562 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL28875703 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL21270014 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL21270036 | 0.97 | AKR1B1 (0.40) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL5859570 | 0.95 | AKR1B1 (0.44) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL5859384 | 0.95 | AKR1B1 (0.39) | AKR1B1GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 936 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4017840-B1 | FAST PREPARATION OF LOW PRIMARY AMINE CONTAINING POLYASPARTIC ESTERS AND USE OF THESE POLYASPARTIC ESTERS IN SLOW REACTIVITY POLYUREA SYSTEMS | COVESTRO LLC (US) | 2024-09-25 | — | — | EP | claimed |
| US-11912832-B2 | Organic-inorganic polymeric compositions, related articles, and related methods | EASTERN MICHIGAN UNIVERSITY (US) | 2024-02-27 | — | — | US | claimed |
| EP-3438083-B1 | ALKOXY MAGNESIUM, METHOD FOR PRODUCING ALKOXY MAGNESIUM, SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION USE, CATALYST FOR OLEFIN POLYMERIZATION USE, AND METHOD FOR PRODUCING OLEFIN POLYMER | TOHO TITANIUM CO LTD (JP) | 2023-08-16 | — | — | EP | claimed |
| US-20220348724-A1 | ORGANIC-INORGANIC POLYMERIC COMPOSITIONS, RELATED ARTICLES, AND RELATED METHODS | EASTERN MICHIGAN UNIVERSITY | 2022-11-03 | — | — | US | claimed |
| EP-3662044-B1 | DETERGENT ADDITIVE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-08-03 | — | — | EP | claimed |
| EP-3789464-B1 | INK COMPOSITION FOR ORGANIC LIGHT EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2022-03-30 | — | — | EP | claimed |
| US-20220056171-A1 | Isocyanate Free Binder | ARXADA AG (CH) | 2022-02-24 | — | — | US | claimed |
| CN-110643032-B | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2022-01-28 | — | — | CN | claimed |
| EP-3909702-A1 | ISOCYANATE FREE BINDER | Lonza Solutions AG (CH) | 2021-11-17 | — | — | EP | claimed |
| CN-113438992-A | Isocyanate-free adhesives | 隆萨解决方案股份公司 | 2021-09-24 | — | — | CN | claimed |
| US-20060089481-A1 | Blocked biuretized isocyanates | BAYER MATERIALSCIENCE LLC | 2006-04-27 | — | — | US | claimed |
| EP-1650244-A1 | Blocked biuretized isocyanates | Bayer MaterialScience LLC (US) | 2006-04-26 | — | — | EP | claimed |
| EP-1125577-B1 | Liquid drug delivery compositions | QLT USA INC (US) | 2006-02-15 | — | — | EP | claimed |
| US-20060004005-A1 | Triazines derivatives as cell adhesion inhibitors | SATTIGERI VISWAJANANI J | 2006-01-05 | — | — | US | claimed |
| EP-0754032-B1 | LIQUID DELIVERY COMPOSITIONS | ATRIX LAB INC (US) | 2001-12-05 | — | — | EP | claimed |
| EP-1059328-A1 | One-component polyurethane foam compositions with improved curing behaviour | HILTI Aktiengesellschaft (LI) | 2000-12-13 | — | — | EP | claimed |
| EP-0086473-B2 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | Montedison S.p.A. (IT) | 1992-11-11 | — | — | EP | claimed |
| EP-0086473-B1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | Montedison S.p.A. (IT) | 1987-05-20 | — | — | EP | claimed |
| EP-0050762-B1 | PROCESS FOR THE PREPARATION OF VINYLCYCLOPROPANE DERIVATIVES | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1984-06-13 | — | — | EP | claimed |
| EP-0025846-B1 | IMPROVED PROCESS FOR THE PREPARATION OF VINYLCYCLOPROPANE DERIVATIVES | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1984-03-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004005-A1 | Triazines derivatives as cell adhesion inhibitors | ICAM1, VCAM1, CD74 | AKR1B1 407/4885GPR84 143/4885PPARG 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.